Axsome Therapeutics (AXSM) Q3 2024 Earnings Report

1 Followers

MX:AXSM Q3 2024 EPS Results

Actual EPS: -MXN 24.92
Consensus EPS: -MXN 25.72
Beat/Miss: Beat by +MXN 0.80
One Year Ago EPS: -MXN 24.55

MX:AXSM Q3 2024 Revenue Results

Actual Revenue: MXN 1.95B
Expected Revenue: MXN 1.83B
Beat/Miss: Beat by +MXN 118.87M
YoY Revenue Growth: +81.27%

Earnings Announcement Details

Quarter: Q3 2024
Date: 11/12/2024
Time: Before Open
Conference Call: Tuesday, November 12, 2024

MX:AXSM Upcoming Earnings

Axsome Therapeutics's next earnings date is estimated for March 1, 2027, based on past reporting schedules.

Q3 2024 Earnings Call Audio

MX:AXSM Q3 2024 Earnings Call

0:00 / 0:00

Q3 2024 Earnings Slide Deck

Q3 2024 Earnings Call Summary

No earnings call summary is available for this earnings event.

MX:AXSM Earnings History

MX:AXSM earnings history
Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Press Release
Mar 01, 2027	2026 (Q4)	-0.89-	-10.42	―	―
Nov 02, 2026	2026 (Q3)	-11.79-4.65	-17.48	73.40% (+12.83)
Aug 10, 2026	2026 (Q2)	-16.59-18.41	-18.04	-2.06% (-0.37)
May 04, 2026	2026 (Q1)	-15.70-23.44	-22.69	-3.28% (-0.74)
Feb 23, 2026	2025 (Q4)	-12.91-10.42	-28.64	63.64% (+18.23)
Nov 03, 2025	2025 (Q3)	-16.01-17.48	-24.92	29.85% (+7.44)
Aug 04, 2025	2025 (Q2)	-19.62-18.04	-31.06	41.92% (+13.02)
May 05, 2025	2025 (Q1)	-25.13-22.69	-26.78	15.28% (+4.09)
Feb 18, 2025	2024 (Q4)	-18.62-28.64	-38.69	25.96% (+10.04)
Nov 12, 2024	2024 (Q3)	-25.72-24.92	-24.55	-1.52% (-0.37)
Aug 05, 2024	2024 (Q2)	-24.31-31.06	-28.64	-8.44% (-2.42)
May 06, 2024	2024 (Q1)	-22.41-26.78	-4.84	-453.85% (-21.95)
Feb 20, 2024	2023 (Q4)	-21.78-38.69	-26.23	-47.52% (-12.46)
Nov 06, 2023	2023 (Q3)	-22.38-24.55	-19.9	-23.36% (-4.65)
Aug 07, 2023	2023 (Q2)	-22.56-28.64	-19.72	-45.28% (-8.93)
May 08, 2023	2023 (Q1)	-24.25-4.84	-19.16	74.76% (+14.32)
Feb 27, 2023	2022 (Q4)	-20.94-26.23	-16.74	-56.67% (-9.49)
Nov 07, 2022	2022 (Q3)	-19.53-19.90	-17.3	-15.05% (-2.60)
Aug 09, 2022	2022 (Q2)	-18.71-19.72	-16	-23.26% (-3.72)
May 02, 2022	2022 (Q1)	-18.66-19.16	-14.51	-32.05% (-4.65)
Mar 01, 2022	2021 (Q4)	-19.01-16.74	-14.51	-15.38% (-2.23)
Nov 08, 2021	2021 (Q3)	-17.74-17.30	-11.35	-52.46% (-5.95)
Aug 09, 2021	2021 (Q2)	-17.09-16.00	-9.11	-75.51% (-6.88)
May 10, 2021	2021 (Q1)	―-14.51	-16.37	11.36% (+1.86)
Mar 01, 2021	2020 (Q4)	―-14.51	-13.21	-9.86% (-1.30)
Nov 05, 2020	2020 (Q3)	―-11.35	-10.42	-8.93% (-0.93)
Aug 10, 2020	2020 (Q2)	―-9.11	-7.63	-19.51% (-1.49)
May 08, 2020	2020 (Q1)	―-16.37	-5.95	-175.00% (-10.42)
Mar 12, 2020	2019 (Q4)	―-13.21	-5.95	-121.88% (-7.25)
Nov 07, 2019	2019 (Q3)	―-10.42	-5.77	-80.65% (-4.65)
Aug 08, 2019	2019 (Q2)	―-7.63	-5.95	-28.13% (-1.67)
May 09, 2019	2019 (Q1)	―-5.95	-3.53	-68.42% (-2.42)
Mar 14, 2019	2018 (Q4)	―-5.95	-5.77	-3.23% (-0.19)
Nov 09, 2018	2018 (Q3)	―-5.77	-5.02	-14.81% (-0.74)
Aug 08, 2018	2018 (Q2)	―-5.95	-5.58	-6.67% (-0.37)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed

Axsome Therapeutics earnings date